CHRISTINE OGLE: Open Payments
NPI 1134541352 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 14 payments from 7 companies in 2025. Trend: 2023 $210 · 2024 $165 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $152 |
| ABBVIE INC. | 6 | $105 |
| ABIOMED | 2 | $93 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: COREVALVE EVOLUT R, AVYCAZ, ZERBAXA, PIFELTRO, JARDIANCE, Rezzayo, CLEVIPREX.
Industry payments across NJ — which companies pay providers there.
